v3.26.1
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 15, 2025
Mar. 31, 2026
Feb. 28, 2026
Jan. 31, 2026
Aug. 31, 2025
Feb. 28, 2026
Nov. 30, 2025
May 31, 2026
Feb. 28, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Common stock, shares authorized         100,000,000     100,000,000  
Common stock, par or stated value per share         $ 0.01     $ 0.01  
Preferred stock, shares authorized         10,000,000     10,000,000  
Preferred stock, par or stated value per share         $ 0.001     $ 0.001  
Cash consideration               $ 630,000  
Issuance of shares               6,187,472  
Redemption-exchange Agreement [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock options exercised     340,000            
Stock options exercise price     $ 1.97            
Common Stock [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Warrants exercised           6,768,571 2,100,000    
Stock options exercised     45,250       257,407    
Share-Based Payment Arrangement, Option [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Stock options exercised             500,000    
Stock options exercise price             $ 1.31    
Director [Member] | Share-Based Payment Arrangement [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Number of shares issued 123,132 123,581   111,729          
Compensation expense           $ 81,399 $ 87,000    
Unsecured Notes [Member]                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                  
Debt principal amount                 $ 1,098,000
Shares issued upon conversion of notes         3,660,000        
Warrants number of shares               8,880,000 10,980,000
Warrants exercised               2,100,000  
Warrants exercise price               $ 0.30